2,402
Views
9
CrossRef citations to date
0
Altmetric
Review

Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings

ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 977-990 | Received 22 May 2020, Accepted 28 Aug 2020, Published online: 20 Sep 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Maria Gabriella Matera, Barbara Rinaldi, Carmela Belardo & Mario Cazzola. (2022) Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overview. Expert Review of Clinical Pharmacology 15:11, pages 1269-1281.
Read now
Mario Cazzola, Josuel Ora, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2022) Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today?. Expert Opinion on Pharmacotherapy 23:8, pages 917-927.
Read now
Beatrice Ludovica Ritondo, Ermanno Puxeddu, Luigino Calzetta, Mario Cazzola & Paola Rogliani. (2021) Efficacy and safety of triple combination therapy for treating chronic obstructive pulmonary disease: an expert review. Expert Opinion on Pharmacotherapy 22:5, pages 611-620.
Read now

Articles from other publishers (6)

Ioannis Konstantinidis, Kristina Crothers, Ken M. Kunisaki, M. Bradley Drummond, Thomas Benfield, Heather J. Zar, Laurence Huang & Alison Morris. (2023) HIV-associated lung disease. Nature Reviews Disease Primers 9:1.
Crossref
Brooke Foster, Daniel Obidare‐Kolade & Michael Nagy. (2023) Assessment of primary care provider and pharmacist knowledge, comfort, and barriers to appropriate inhaled corticosteroid use in chronic obstructive pulmonary disease. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 6:4, pages 339-345.
Crossref
Michelle N. Schroeder, Hailee M. Sens & Shaina K. Shah. (2022) De-Prescribing Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: A Narrative Review. Journal of Pharmacy Practice, pages 089719002211441.
Crossref
浩 杨. (2022) Research Progress on Discontinuation of ICS with Triple Inhaled Drugs for Chronic Obstructive Pulmonary Disease. Advances in Clinical Medicine 12:07, pages 6963-6974.
Crossref
Paola Rogliani, Beatrice Ludovica Ritondo, Francesco Facciolo, Maria Gabriella Matera, Ivan Nikolaev & Luigino Calzetta. (2021) Indacaterol, glycopyrronium, and mometasone: Pharmacological interaction and anti-inflammatory profile in hyperresponsive airways. Pharmacological Research 172, pages 105801.
Crossref
Jennifer K. Quint, Jukka Montonen, Daina B. Esposito, Xintong He, Leslie Koerner, Laura Wallace, Alberto de la Hoz & Marc Miravitlles. (2021) Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database. Advances in Therapy 38:5, pages 2249-2270.
Crossref